Daidzein-Estrogen interaction in the rat uterus and its effect on human breast cancer cell growth

Journal of Medicinal Food

Volumn 15, Issue 12, 2012, Pages 1081-1090

  Gaete, Leonardo ^a   Tchernitchin, Andrei N ^a   Bustamante, Rodrigo ^a   Villena, Joan ^b   Lemus, Igor ^c   Gidekel, Manuel ^d   Cabrera, Gustavo ^d   Astorga, Paola ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSIDAD ADOLFO IBÁÑEZ   (Chile)

Author keywords

Cancer cells; Cell growth; Daidzein; Estradiol; Genistein; Mammary tumor; Uterus

Indexed keywords

DAIDZEIN; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL PROLIFERATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG INTERACTIONS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; ISOFLAVONES; MCF-7 CELLS; PHYTOESTROGENS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS; UTERUS;

ANIMALIA; RATTUS;

EID: 84871195946     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.0322     Document Type: Article

References (62)

1. Beral V: Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-427. (Pubitemid 36999703)
2. Lyytinen H, Pukkala E, Ylikorkala O: Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354-1360. (Pubitemid 44901007)
3. Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C, Cesana G, Contiero P, Tagliabue G, Nappi RE, Merlino L: Menopause hormone replacement therapy and cancer risk: An Italian record linkage investigation. Ann Oncol 2008;19:150-155.
4. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
5. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E: Women's Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350:991-1004. (Pubitemid 38269276)
6. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA: Testosterone inhibits estrogen-Induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000;14:1725-1730.
7. Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V: Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res 2009;69: 6149-6157.
8. Jensen EV, DeSombre ER: Mechanism of action of the female sex hormones. Annu Rev Biochem 1972;41:203-230.
9. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A° : Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930. (Pubitemid 26190778)
10. Wang H, Masironi B, Eriksson H, Sahlin L: A comparative study of estrogen receptors a and b in the rat uterus. Biol Reprod 1999; 61:955-965.
11. Damdimopoulos AE, Spyrou G, Gustafsson J-A° : Ligands differentially modify the nuclear mobility of estrogen receptors a and b. Endocrinology 2008;149:339-345.
12. Tchernitchin A, Tchernitchin X, Robel P, Baulieu EE: Liaison de l'oestradiol dans les leucocytes polynucle'aires e'osinophiles humains. C R Acad Sci Paris 1974;280D:1477-1480.
13. Tchernitchin AN, Mena MA, Rodri'guez A, Maturana M: Radioautographic localization of estrogen receptors in the rat uterus: A tool for the study of classical and nontraditional mechanism of hormone action. In: Localization of Putative Steroid Receptors, Vol. 1 (Pertschuk LP, Lee SH, eds.). CRC Press, Boca Raton, FL, 1985, pp. 5-37.
14. Tchernitchin AN, Mena MA, Soto J, Unda C: The role of eosinophils in the action of estrogens and other hormones. Med Sci Res 1989;17:5-10. (Pubitemid 19031808)
15. Pietras RJ, Szego CM: Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 1980;191:743-760. (Pubitemid 11223633)
16. Nenci I, Fabris G, Marzola A, Marchetti E: The plasma membrane as an additional level of steroid-Cell interaction. J Steroid Biochem 1981;15:231-234. (Pubitemid 12069243)
17. Markaverich BM, Upchurch S, Clark JH: Progesterone and dexamethasone antagonism of uterine growth: A role for a second nuclear binding site for estradiol in estrogen action. J Steroid Biochem 1981;14:125-132. (Pubitemid 11102069)
18. Sutherland RL, Murphy LC, San Foo M, Green MD, Whybourne AM: High-Affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature 1980;288:273-275. (Pubitemid 11165875)
19. Tchernitchin A, Rooryck J, Tchernitchin X, Vandenhende J, Galand P: Effects of cortisol on uterine eosinophilia and other oestrogenic responses. Mol Cell Endocrinol 1975;2:331-337.
20. Tchernitchin AN, Galand P: Dissociation of separate mechanisms of estrogen action by actinomycin D. Experientia 1982; 38:511-513. (Pubitemid 12070221)
21. Tchernitchin AN, Galand P: Oestrogen levels in the blood, not in the uterus, determine uterine eosinophilia and oedema. J Endocrinol 1983;99:123-130. (Pubitemid 13022981)
22. Tchernitchin NN, Clavero A, Mena MA, Unda C, Villagra R, Cumsille M, Tchernitchin AN: Effect of chronic exposure to lead on estrogen action in the prepubertal rat uterus. Environ Toxicol 2003;18:268-277. (Pubitemid 37009919)
23. Tchernitchin AN, Olivares F, Aranda C, Bustamante RA, Gaete L, Ferrada K, Villagra R, Vera J, Iturbe RJ, Kim YA, Herna'ndez NB, Bizjak T, Novsak S: Efectos de exposicio'n aguda a cadmio en la accio'n de estro'genos en u'tero de rata impu'ber. Rev Chil Pediatr 2008;79:373-380.
24. Adlercreutz H: Phyto-oestrogens and cancer. Lancet Oncol 2002; 3:364-373. (Pubitemid 34661986)
25. Adlercreutz H: Epidemiololgy of phytoestrogens. Bailliè res Clin Endocrinol Metab 1998;12:605-623.
26. Mense SM, Hei TK, Ganju RK, Bhat HK: Phytoestrogens and breast cancer prevention: Possible mechanisms of action. Environ Health Perspect 2008;116:426-433. (Pubitemid 351864298)
27. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W: Soy food intake and breast cancer survival. JAMA 2009;302:2437-2443.
28. Paulo M, Salvador MM, Filho MA, Bonetti M, Montes A, Francheschini SA, Toloi MR: Effect of isoflavone extracts from Glycine max on human endothelial cell damage and on nitric oxide production. Menopause 2009;16:539-544.
29. Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlova-Wuttke D: Phytoestrogens: Endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2003;44 SUPPL1:S9-S20. (Pubitemid 36263031)
30. Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlova-Wuttke D: Phytoestrogens: Endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2008;61:159-170.
31. Cederroth CR, Nef S: Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol 2009;304:30-42.
32. Baber R: Phytoestrogens and post reproductive health. Maturitas 2010;66:344-349.
33. Gaete L, Tchernitchin AN, Bustamante R, Villena J, Ferrada K, Erazo S, Garci'a R, Lemus I: Biological activity of genistein and soy extracts: Selective induction of some but not all estrogenic responses in the prepubertal rat uterus. Bol Latinoam Caribe Plant Med Aromat 2010;9:302-311.
34. Gaete L, Tchernitchin AN, Bustamante R, Villena J, Lemus I, Gidekel M, Cabrera G, Carrillo O: Genistein selectively inhibits estrogen-Induced cell proliferation and some other responses to hormone stimulation in the prepubertal rat uterus. J Med Food 2011;14:1597-1603.
35. Messina MJ, Persky V, Setchel KDR, Barnes S: Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-131. (Pubitemid 24127628)
36. Wang TT, Sathyamoorthy N, Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996;17:271-275. (Pubitemid 26091305)
37. Liu H, Du J, Hu C, Qi H, Wang X, Wang S, Liu Q, Li Z: Delayed activation of extracellular-Signal-regulated kinase 1/2 is involved in genistein- And equol-Induced cell proliferation and estrogenreceptor-Alpha-mediated transcription in MCF-7 breast cancer cells. J Nutr Biochem 2010;21:390-396.
38. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG: Dietary genistein results in larger NMU-Induced, estrogen-Dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004;25:211-218. (Pubitemid 38239804)
39. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-Dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002;62:2474-2477. (Pubitemid 34462720)
40. Tchernitchin AN, Lo'pez-Solis RO, Cartes R, Rodri'guez A, Mena MA, Unda C: Developmental changes of estrogenic responses in the rat uterus. J Steroid Biochem 1980;13:1369-1371. (Pubitemid 11201134)
41. Tchernitchin A, Tchernitchin X, Galand P: Correlation of estrogen-Induced uterine eosinophilia with other parameters of estrogen stimulation, produced with estradiol-17ß and estriol. Experientia 1975;31:993-994.
42. Grunert G, Porcia M, Tchernitchin AN: Differential potency of oestradiol-17ß and diethylstilbestrol on separate groups of responses in the rat uterus. J Endocrinol 1986;110:103-114. (Pubitemid 16057289)
43. Grunert G, Neumann G, Porcia M, Tchernitchin AN: The estrogenic responses to clomiphene in the different cell-Types of the rat uterus: Morphometrical evaluation. Biol Reprod 1987;37: 527-538. (Pubitemid 18078432)
44. Grunert G, Ferna'ndez S, Tchernitchin AN: Methods for the evaluation of responses to estrogen in individual cell types or regions of the uterus. Horm Res 1984;19:253-262. (Pubitemid 14117656)
45. Tchernitchin A, Roorijck J, Tchernitchin X, Vandenhende J, Galand P: Dramatic early increase in uterine eosinophils after oestrogen administration. Nature 1974;248:142-143.
46. Tchernitchin AN, Barrera J, Arroyo P, Mena MA, Vilches K, Grunert G: Degranulatory action of estradiol on blood eosinophil leukocytes in vivo and in vitro. Agent Actions 1985;17:60-66. (Pubitemid 16179296)
47. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-Drug screening. J Natl Cancer Inst 1990;82:1107-1112. (Pubitemid 20213250)
48. Vichai V, Kirtikara K: Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006;1:1112-1116.
49. Snedecor GW, Cochran WG: Two-way classifications. In: Statistical Methods, 6th ed. (Snedecor GW, Cochran WG, eds.). Iowa State University Press, Ames, IA, 1967, pp. 299-338.
50. Charlier TD: Importance of steroid receptor coactivators in the modulation of steroid action on brain and behavior. Psychoneuroendocrinology 2009;34 SUPPL1:S20-S29.
51. Fowler AM, Santen RJ, Allred DC: ''Dwarf'' estrogen receptor in breast cancer and resistance to tamoxifen. J Clin Oncol 2009; 27:3413-3415.
52. Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Wang Z, Xie Y: Expression of ER-A 36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 2009;27:3423-3429.
53. Klinge CM, Riggs KA, Wickramasinghe NS, Emberts CG, McConda DB, Barry PN, Magnusen JE: Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and reexpression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription. Mol Cell Endocrinol 2010;323:268-276.
54. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M, Fournier B: Evidence for ligand-Independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): Crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-Activated receptor coactivator-1alpha. J Biol Chem 2004;279:49330-49337. (Pubitemid 39625820)
55. Giguère V: Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008;29:677-696.
56. Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, He F: MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One 2012;7:e39102.
57. Reynolds PD, Ruan Y, Smith DF, Scammell JG: Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab 1999;84:663-669. (Pubitemid 29075703)
58. McKeen HD, Byrne C, Jithesh PV, Donley C, Valentine A, YakkundiA, O'Rourke M, Swanton C,McCarthy HO, Hirst DG, Robson T: FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res 2010;70:1090-1100.
59. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F: Identification of a new isoform of the human estrogen receptor-Alpha (hER-Alpha) that is encoded by distinct transcripts and that is able to repress hER-Alpha activation function 1. EMBO J 2000;19:4688-4700.
60. Kurzer MS: Phytoestrogen supplement use by women. J Nutr 2003;133:1983S-1986S. (Pubitemid 36666547)
61. Jin S, Zhang QY, Kang XM, Wang JX, Zhao WH: Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann Oncol 2010;21:263-268.
62. Rachon D, Menche A, Vortherms T, Seidlova-Wuttke D, Wuttke W: Effects of dietary equol administration on the mammary gland in ovariectomized Sprague-Dawley rats. Menopause 2008; 15:340-345. (Pubitemid 351354997)